| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8443598 | European Journal of Cancer | 2014 | 7 Pages |
Abstract
In patients with mRCC with renal insufficiency, sunitinib was efficacious and did not cause increased toxicity. Thus, clinicians should not hesitate to treat patients with mRCC with renal insufficiency with sunitinib.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ki Hyang Kim, Ho Young Kim, Hye Ryun Kim, Jong-Mu Sun, Ho Yeong Lim, Hyo Jin Lee, Suee Lee, Woo Kyun Bae, Sun Young Rha, Korean Cancer Study Group Korean Cancer Study Group,